Stelis Biopharma
Manufacturing · India · 201-500 Employees
View Company Info for Free
Overview
Headquarters
IndiaWebsite
www.stelisbiosource.comRevenue
$15.3 MillionIndustry
About Stelis Biopharma
Stelis Biopharma Org Chart
Is Stelis Biopharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Stelis Biopharma recently announced quarterly report
Product Launch: Get notified when Stelis Biopharma launches new products
Website visits: Recent activity has been detected on your website
Stelis Biopharma, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Stelis Biopharma has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Stelis Biopharma
Click to see if Stelis Biopharma had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Stelis Biopharma has new funding data
Check out if Stelis Biopharma is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Stelis Biopharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Stelis Biopharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Stelis Biopharma.
Stelis Biopharma financials insights
Gather financial insights about Stelis Biopharma, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Private Equity
$8.5M
Stelis Biopharma Tech Stack
A closer look at the technologies used by Stelis Biopharma
Most Recent Scoops
Stelis Biopharma News & Media
Biolexis and Akston Biosciences Announce Encouraging Top-Line Results from Phase II/III Trial of their Thermostable 2nd Gen COVID-19 Vaccine
BEVERLY, Mass. & BANGALORE, India--(BUSINESS WIRE)-- #AKS452--Biolexis, Akston Biosciences announce top-line results: 91% seroconversion rate from Phase II/III trial of their thermostable COVID-19 vaccine.Akston Biosciences and Biolexis Collaborate to Launch a Room Temperature Stable 2nd Generation COVID-19 Vaccine in 130+ Countries
BEVERLY, Mass. & BANGALORE, India--(BUSINESS WIRE)-- #AKS452--Akston Biosciences & Biolexis collaborate to launch a room temperature stable 2nd-gen COVID vaccine in 130+ countries; expects EUA in India June 2022Stelis Biopharma Appoints Mark Womack as CEO
Assumes the role of chief executive with immediate effect and will be stationed at Stelis HQ in Bengaluru, India.
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Stelis Biopharma
Stelis is a vertically integrated biopharmaceutical company. Stelis offers end-to-end state-of-the-art CDMO services across all phases of pre-clinical and clinical development and commercial supply of biologics. Its operations include R&D, process development, scale-up & end-to- end cGMP manufacturing capabilities from drug substance through drug p... Read More